Mankind Pharma Ltd Share Price – NSE  / BSE

Pharmaceuticals, Mid Cap

Mankind Pharma will hold a meeting of the Board of Directors of the Company on 3 February 2026.

Powered by Capital Market - Live News

Mankind Pharma Ltd is up for a fifth straight session today. The stock is quoting at Rs 2228.7, up 1.94% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is up around 0.01% on the day, quoting at 26175.65. The Sensex is at 85535.57, down 0.04%. Mankind Pharma Ltd has gained around 0.27% in last one month.

Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has gained around 1.82% in last one month and is currently quoting at 22927.9, down 0.11% on the day. The volume in the stock stood at 3.36 lakh shares today, compared to the daily average of 4.94 lakh shares in last one month.

The benchmark December futures contract for the stock is quoting at Rs 2231.3, up 2.1% on the day. Mankind Pharma Ltd is down 23.43% in last one year as compared to a 10.32% jump in NIFTY and a 1.52% jump in the Nifty Pharma index.

The PE of the stock is 54.2 based on TTM earnings ending September 25.

Powered by Capital Market - Live News

Mankind Pharma has allotted 46,582 equity shares under ESOP on 26 November 2025. With this allotment, the paid up equity share capital has increased to 41,28,05,072 equity shares having face value of Re 1/- each.

Powered by Capital Market - Live News

Mankind Pharma Ltd dropped for a fifth straight session today. The stock is quoting at Rs 2222.3, down 0.64% on the day as on 13:19 IST on the NSE. The benchmark NIFTY is up around 0.14% on the day, quoting at 25609.05. The Sensex is at 83614.62, up 0.09%.Mankind Pharma Ltd has eased around 9.02% in last one month.Meanwhile, Nifty Pharma index of which Mankind Pharma Ltd is a constituent, has increased around 0.57% in last one month and is currently quoting at 22379.85, down 0.22% on the day. The volume in the stock stood at 2.28 lakh shares today, compared to the daily average of 3.64 lakh shares in last one month.

The benchmark November futures contract for the stock is quoting at Rs 2231.5, down 0.72% on the day. Mankind Pharma Ltd tumbled 15.25% in last one year as compared to a 7.23% rally in NIFTY and a 0.81% spurt in the Nifty Pharma index.

The PE of the stock is 55.39 based on TTM earnings ending September 25.

Powered by Capital Market - Live News